Howard Hughes (HHH) Reports 12% Revenue Increase in Q4 2025

By Chris Stiles • Wednesday, February 04 11:39 • Permanent Link

In the recent press release, HHC has provided preliminary unaudited estimated selected financial information for the quarterly and annual periods ending December 31, 2025. The company's preliminary estimates include unaudited estimated financial information for the three months and year ended December 31, 2025, as well as actual financial results derived from unaudited interim financial statements for the three months ended December 31, 2024, and audited consolidated financial statements for the year ended December 31, 2024.

For the three months ended December 31, 2025, HHC reported a 12% increase in revenue compared to the same period in 2024, reaching an estimated $150 million. Additionally, the company's net income for the same period is estimated to be $10 million, reflecting a significant improvement from the previous year.

Looking at the annual period ended December 31, 2025, HHC's preliminary estimates indicate a 9% increase in annual revenue, totaling approximately $600 million. The company's net income for the year is estimated to be $40 million, demonstrating a notable rise compared to the prior year.

It's important to note that the final results are subject to the completion of management's review and other closing procedures, as well as the audit of HHC's financial statements. HHC's independent registered public accounting firm, KPMG LLP, has not audited, reviewed, or performed any procedures with respect to the preliminary financial information.

Investors and stakeholders are advised to consider the preliminary financial information in conjunction with the associated risk factors and cautionary statements provided by the company.

The company's management is responsible for the preparation of the preliminary financial information, and it should not be viewed as a substitute for full audited financial statements prepared in accordance with GAAP. The audit of HHC's consolidated financial statements for the year ended December 31, 2025, will be finalized after the completion of the offering.

While the preliminary results indicate positive growth in revenue and net income for HHC, it's important to await the final audited financial statements to accurately assess the company's performance for the specified periods. Following these announcements, the company's shares moved 0.29%, and are now trading at a price of $83.66. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.